Oluwatomisin Atolagbe to CD8-Positive T-Lymphocytes
This is a "connection" page, showing publications Oluwatomisin Atolagbe has written about CD8-Positive T-Lymphocytes.
Connection Strength
0.085
-
ICOS costimulation in combination with CTLA-4 blockade remodels tumor-associated macrophages toward an antitumor phenotype. J Exp Med. 2024 Apr 01; 221(4).
Score: 0.047
-
LILRB4 suppresses immunity in solid tumors and is a potential target for immunotherapy. J Exp Med. 2021 07 05; 218(7).
Score: 0.038